Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hormone replacement therapy in hypopituitarism.

Jamie C Smith¹

¹Department of Diabetes & Endocrinology, Torbay Hospital, Lawes Bridge, Torquay, UK. jamie.smith@nhs.net

Expert Opinion on Pharmacotherapy

|May 25, 2004

Summary

Hypopituitarism causes hormone deficiencies, often due to pituitary adenomas. Effective management requires tailored hormone replacement therapy to prevent complications and improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antibiotic-Induced Bacterial Cell Death: A "Radical" Way of Dying?

Current topics in microbiology and immunology·2025

Same author

Mosquito midgut stem cell cellular defense response limits Plasmodium parasite infection.

Nature communications·2024

Same author

Mosquito midgut stem cell cellular defense response limits <i>Plasmodium</i> parasite infection.

bioRxiv : the preprint server for biology·2023

Same author

Hypertonic saline versus fluid restriction: The pitfalls in managing acute hyponatremia in a patient with long-standing spinal cord injury.

Clinical case reports·2022

Same author

Lipohypertrophy contributing to severe diabetic ketoacidosis in type 1 diabetes: An increasing problem in the context of the COVID-19 pandemic?

Clinical case reports·2022

Same author

Colesevelam-induced hypoglycaemia in a patient with type 1 diabetes mellitus.

Clinical case reports·2021

Area of Science:

Endocrinology
Internal Medicine

Background:

Hypopituitarism involves deficiencies in pituitary hormones, frequently caused by pituitary adenomas or their treatment.
Tumor pressure and surgical intervention can lead to varying degrees of hypopituitarism, causing nonspecific symptoms and end-organ failure.

Purpose of the Study:

To outline the management principles for hypopituitarism, focusing on symptom amelioration and complication prevention.
To highlight the challenges in achieving physiological hormone replacement and the need for individualized therapeutic strategies.

Main Methods:

Review of management strategies for hypopituitarism.
Discussion of lifelong hormone replacement therapies, including corticosteroids, sex hormones, growth hormone, and vasopressin.

Main Results:

Hormone replacement therapy aims to correct deficiencies but can lead to unphysiological levels and administration/monitoring issues.
The hypopituitary state is linked to increased cardiovascular mortality, potentially due to growth hormone deficiency or suboptimal hormone replacement.

Conclusions:

Tailoring hormone replacement regimens to individual patient needs is crucial for addressing the increased morbidity and mortality associated with hypopituitarism.
Further research is needed to elucidate mechanisms of cardiovascular risk and optimize therapeutic approaches.

Related Experiment Videos